Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · IEX Real-Time Price · USD
45.57
-1.41 (-3.00%)
At close: Jul 19, 2024, 4:00 PM
45.54
-0.03 (-0.07%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $422.57 million as of July 22, 2024. Its market cap has increased by 3,280.56% in one year.
Market Cap
422.57M
Enterprise Value
316.14M
1-Year Change
3,280.56%
Ranking
Category
Stock Price
$45.57
Market Cap Chart
Since October 3, 2019, Korro Bio's market cap has decreased from $426.80M to $422.57M, a decrease of -0.99%. That is a compound annual growth rate of -0.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 422.60M | 10.20% |
| Dec 29, 2023 | 383.50M | 182.40% |
| Dec 30, 2022 | 135.80M | -23.49% |
| Dec 31, 2021 | 177.50M | -85.08% |
| Dec 31, 2020 | 1.19B | 120.40% |
| Dec 31, 2019 | 539.70M | 26.45% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 431.58M |
| Taysha Gene Therapies | 430.95M |
| Aura Biosciences | 429.54M |
| Health Catalyst | 428.59M |
| Ocugen | 427.21M |
| C4 Therapeutics | 414.90M |
| Editas Medicine | 411.19M |
| Anika Therapeutics | 409.47M |